In the last trading session, 2.32 million Avadel Pharmaceuticals plc (NASDAQ:AVDL) shares changed hands as the company’s beta touched 1.63. With the company’s per share price at $18.09 changed hands at $1.09 or 6.41% during last session, the market valuation stood at $1.72B. AVDL’s last price was a premium, traded about 0.44% off its 52-week high of $18.01. The share price had its 52-week low at $9.50, which suggests the last value was 47.48% up since then. When we look at Avadel Pharmaceuticals plc’s average trading volume, we note the 3-month average coming to 1.22 million.

Avadel Pharmaceuticals plc (NASDAQ:AVDL) trade information

Instantly AVDL was in green as seen at the end of in last trading. With action 7.87%, the performance over the past five days has been green. The jump to weekly highs of 18.85 added 6.41% to the stock’s daily price. The company’s shares are showing year-to-date upside of 28.12%, with the 5-day performance at 7.87% in the green. However, in the 30-day time frame, Avadel Pharmaceuticals plc (NASDAQ:AVDL) is 13.63% up.

Avadel Pharmaceuticals plc (AVDL) estimates and forecasts

Data shows that the Avadel Pharmaceuticals plc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 71.96% over the past 6 months, a 77.00% in annual growth rate that is considerably higher than the industry average of 9.60%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 4.78%. The 2024 estimates are for Avadel Pharmaceuticals plc earnings to increase by 78.11%, but the outlook for the next 5-year period is at 15.00% per year.

AVDL Dividends

Avadel Pharmaceuticals plc is expected to release its next quarterly earnings report in May.